Literature DB >> 11128613

Subcellular localization of alpha-synuclein in primary neuronal cultures: effect of missense mutations.

P J McLean1, S Ribich, B T Hyman.   

Abstract

Numerous recent observations have implicated alpha-synuclein in the pathogenesis of several neurodegenerative diseases, including Parkinson's disease, Alzheimer's disease, dementia with Lewy bodies and multiple-system atrophy. Two missense mutations in the gene for alpha-synuclein have been identified in some cases of familial Parkinson's disease and it is thought that these may disrupt the normal structure of the protein and thus promote aggregation into Lewy body filaments. Here, we examine the subcellular localization of alpha-synuclein in primary cortical neurons maintained in a monolayer culture. The protein has widespread expression throughout neurons, including the nucleus, and has a discete localization in the neurites of more mature neurons, reminiscent of synaptic specializations. Interestingly, in a subpopulation of cortical neurons transfected at 13 days in vitro, we find that alpha-synuclein appears to aggregate into distinct punctate inclusions in the cytoplasm and proximal neurites. Unlike Lewy bodies, these structures are not ubiquitin positive. These regions of alpha-synuclein accumulation are observed following transfections with wild-type, Ala30Pro or Ala53Thr alpha-synuclein; neither mutation alters their frequency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11128613     DOI: 10.1007/978-3-7091-6284-2_5

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  25 in total

Review 1.  NURR1 in Parkinson disease--from pathogenesis to therapeutic potential.

Authors:  Mickael Decressac; Nikolaos Volakakis; Anders Björklund; Thomas Perlmann
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

2.  Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism.

Authors:  Mikhail Y Golovko; Thad A Rosenberger; Nils J Faergeman; Søren Feddersen; Nelson B Cole; Ingrid Pribill; Johannes Berger; Robert L Nussbaum; Eric J Murphy
Journal:  Biochemistry       Date:  2006-06-06       Impact factor: 3.162

3.  Determining nuclear localization of alpha-synuclein in mouse brains.

Authors:  Z Huang; Z Xu; Y Wu; Y Zhou
Journal:  Neuroscience       Date:  2011-10-19       Impact factor: 3.590

4.  The function of α-synuclein.

Authors:  Jacob T Bendor; Todd P Logan; Robert H Edwards
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

5.  Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.

Authors:  Michael G Schlossmacher; Matthew P Frosch; Wei Ping Gai; Miguel Medina; Nutan Sharma; Lysia Forno; Tomoyo Ochiishi; Hideki Shimura; Ronit Sharon; Nobutaka Hattori; J William Langston; Yoshikuni Mizuno; Bradley T Hyman; Dennis J Selkoe; Kenneth S Kosik
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

6.  Alpha-synuclein expression modulates microglial activation phenotype.

Authors:  Susan A Austin; Angela M Floden; Eric J Murphy; Colin K Combs
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

7.  The mechanistic role of alpha-synuclein in the nucleus: impaired nuclear function caused by familial Parkinson's disease SNCA mutations.

Authors:  Vivian Chen; Malik Moncalvo; Dominic Tringali; Lidia Tagliafierro; Ahila Shriskanda; Ekaterina Ilich; Wendy Dong; Boris Kantor; Ornit Chiba-Falek
Journal:  Hum Mol Genet       Date:  2020-11-04       Impact factor: 6.150

8.  α-Synuclein is prone to interaction with the GC-box-like sequence in vitro.

Authors:  Kai-Li Ma; Lian-Kun Song; Yu-He Yuan; Ying Zhang; Jin-Ling Yang; Ping Zhu; Nai-Hong Chen
Journal:  Cell Mol Neurobiol       Date:  2014-05       Impact factor: 5.046

9.  Establishment of stably transfected rat neuronal cell lines expressing alpha-synuclein GFP fusion proteins.

Authors:  Gert Schwach; Michaela Tschemmernegg; Roswitha Pfragner; Elisabeth Ingolic; Edith Schreiner; Manfred Windisch
Journal:  J Mol Neurosci       Date:  2009-10-09       Impact factor: 3.444

10.  LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease.

Authors:  J Alegre-Abarrategui; O Ansorge; M Esiri; R Wade-Martins
Journal:  Neuropathol Appl Neurobiol       Date:  2007-10-26       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.